Several UAB labs will collaborate with biopharmaceutical company Altimmune, Inc. to explore the immune response of an intranasal COVID-19 vaccine candidate. This data, gathered from six UAB labs in the Department of Microbiology, Department of Anesthesiology and Perioperative Medicine, and the Division of Clinical Immunology and Rheumatology, proceeds progression of the candidate into a Phase I clinical trial. Read the entire story here: https://www.uab.edu/news/research/item/11203-uab-will-test-a-covid-19-vaccine-candidate-created-by-altimmune-inc.
